NCT01551017

Brief Summary

Fast Track Recovery Arthroplasty Project is supposed to analyse a new medical method to accelerate patient's remobilisation process after total knee endoprostheses. The method, called c-treatment, is a computer-controlled cryotherapy (soothing cooling therapy) at which the device measures temperature at the affected site (the operated knee in the investigators investigation) and optimizes the cooling temperature. The optimized cooling therapy is supposed to reduce swelling and postoperative pain whereby patient's postoperative mobilization can be done earlier leading to a reduction of length of hospitalization. To verify c-treatment's efficiency compared to conventional cryotherapy, patients are split in a test group and a standard group. The standard group is treated following the standard protocol at the Department of Orthopaedics Surgery Graz using cold packs (Fa. Dahlhausen, product code 93.000.00.042). Patient's in the test group receive c-treatment therapy following the study protocol. All patients are instructed to fill in standardized questionnaires to evaluate social scores and pain scores preoperative as well as postoperative. The knee's swelling and range of motion as well as blood parameters monitoring the healing process are measured following the study protocol. The comparison of these parameters between the standard and the test group is supposed to verify c-treatment's efficiency.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 12, 2012

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 22, 2015

Status Verified

April 1, 2015

Enrollment Period

3.5 years

First QC Date

March 8, 2012

Last Update Submit

April 21, 2015

Conditions

Keywords

total knee endoprosthesesswellingmobilisation

Outcome Measures

Primary Outcomes (1)

  • swelling

    Change in swelling swelling is measured ad the midpatellar line as well as seven centimeters distal and seven centimeters proximal of the midpatellar line. swelling is measured in centimeters using a standardised measuring tape

    preoperative, 2, 4 and 6 days postoperative

Secondary Outcomes (2)

  • Range of motion

    preoperative, 2,4 and 6 days postoperative

  • Pain

    preoperative, 2,4 and 6 days postoperative

Study Arms (2)

c-treatment

test group

standard cooling

comparison group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients receiving a total knee endoprosthesis at the Department of Orthopaedics Surgery Graz

You may qualify if:

  • degenerative or posttraumatic gonarthrosis or osteonecrosis around the knee
  • scheduled operation for total knee endoprosthesis
  • age between 18 and 90 years
  • patient agrees with study design, therapy and postoperative controls
  • education form is signed by patient and physician

You may not qualify if:

  • Body Mass Index greater than 40
  • varus or valgus deformity greater than 10 degrees
  • impaired extension greater than 10 degrees
  • flexion preoperative less than 90 degrees
  • cold urticaria
  • cryoglobulinemia
  • paroxysmal cold hemoglobinuria
  • current fracture around the knee
  • current infection or status post infection
  • rheumatoid arthritis at knee
  • tumor around the knee
  • any operations done around the knee except arthroscopic knee surgery
  • active systemic infection (HIV, HBV, HCV)
  • obstructive sleep apnea
  • opioid intolerance
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopaedics Surgery Graz - Medical University Graz

Graz, 8020, Austria

RECRUITING

Related Publications (6)

  • Herbold JA, Bonistall K, Walsh MB. Rehabilitation following total knee replacement, total hip replacement, and hip fracture: a case-controlled comparison. J Geriatr Phys Ther. 2011 Oct-Dec;34(4):155-60. doi: 10.1519/JPT.0b013e318216db81.

    PMID: 22124414BACKGROUND
  • Bade MJ, Kohrt WM, Stevens-Lapsley JE. Outcomes before and after total knee arthroplasty compared to healthy adults. J Orthop Sports Phys Ther. 2010 Sep;40(9):559-67. doi: 10.2519/jospt.2010.3317.

    PMID: 20710093BACKGROUND
  • Sultan PG, Most E, Schule S, Li G, Rubash HE. Optimizing flexion after total knee arthroplasty: advances in prosthetic design. Clin Orthop Relat Res. 2003 Nov;(416):167-73. doi: 10.1097/01.blo.0000081937.75404.ee.

    PMID: 14646757BACKGROUND
  • Markert SE. The use of cryotherapy after a total knee replacement: a literature review. Orthop Nurs. 2011 Jan-Feb;30(1):29-36. doi: 10.1097/NOR.0b013e318205749a.

    PMID: 21278552BACKGROUND
  • Adie S, Naylor JM, Harris IA. Cryotherapy after total knee arthroplasty a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2010 Aug;25(5):709-15. doi: 10.1016/j.arth.2009.07.010. Epub 2009 Sep 2.

    PMID: 19729279BACKGROUND
  • Holmstrom A, Hardin BC. Cryo/Cuff compared to epidural anesthesia after knee unicompartmental arthroplasty: a prospective, randomized and controlled study of 60 patients with a 6-week follow-up. J Arthroplasty. 2005 Apr;20(3):316-21. doi: 10.1016/j.arth.2004.09.043.

    PMID: 15809948BACKGROUND

Study Officials

  • Mathias Glehr, MD

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mathias Glehr, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2012

First Posted

March 12, 2012

Study Start

December 1, 2011

Primary Completion

June 1, 2015

Study Completion

December 1, 2016

Last Updated

April 22, 2015

Record last verified: 2015-04

Locations